PORTLAND, Ore., March 6, 2008 (PRIME NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced today the appointment of Stephane Berghmans, D.V.M., Ph.D. to Director of Drug Discovery, effective March 10, 2008.
